To this end, we followed homozygous female Erbb2/Cre/Pfkfb3fl/fl mice for the development of palpable mammary masses and, when tumor development was observed and burden reached ~100 mg, randomized mice to intraperitoneal administration of vehicle ± TAM for 5 days. This evidence concerns the gene ERBB2 and neoplasm.